These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1771715)

  • 1. [Prostatic cancer--clinical and morphometric principles].
    Stamey TA
    Urologe A; 1991 Nov; 30(6):348-60. PubMed ID: 1771715
    [No Abstract]   [Full Text] [Related]  

  • 2. Node-positive prostate cancer. American College of Radiology. ACR Appropriateness Criteria.
    Lee WR; Pollack A; Perez CA; Beyer DC; Blasko JC; Forman JD; Hussey DH; Paryani SB; Potters L; Roach M; Scardino P; Schellhammer P; Leibel S
    Radiology; 2000 Jun; 215 Suppl():1413-8. PubMed ID: 11037556
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results.
    Maffezzini M
    J Urol; 2005 Sep; 174(3):1151-2; author reply 1152. PubMed ID: 16094087
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prognostication of 5-year survival in patients after radical prostatectomy].
    Al'-Shukri SKh; Borovets SIu
    Urologiia; 2005; (6):11-2. PubMed ID: 16419472
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prostatic cancer: clinical situation and treatment strategy].
    Jacobi GH; Hohenfellner R
    Chirurg; 1981 Sep; 52(9):561-9. PubMed ID: 7297207
    [No Abstract]   [Full Text] [Related]  

  • 6. Is radiotherapy useful in node-positive prostate cancer patients after radical prostatectomy?
    Van Poppel H
    Eur Urol; 2009 May; 55(5):1012-3. PubMed ID: 19261377
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical study of total prostatectomy for prostatic cancer].
    Fujii A; Gohji K; Morisue K; Maruyama S; Kizaki T; Oka N
    Hinyokika Kiyo; 1994 Feb; 40(2):111-7. PubMed ID: 8128919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical outcome and analysis of radical prostatectomy in clinical stage B and C prostate cancer].
    Miyoshi Y; Uemura H; Mikata K; Ohuchi H; Jinza S; Yao M; Takeda M; Masuda M; Noguchi S; Noguchi K; Kubota Y; Hosaka M
    Hinyokika Kiyo; 2001 Mar; 47(3):163-8. PubMed ID: 11329956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of 15 years of radical prostatectomy].
    Frohmüller H; Theiss M; Wirth M; Hofmockel G
    Urologe A; 1995 May; 34(3):225-30. PubMed ID: 7610518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alone for pTxN+ prostate cancer: a matched comparison.
    Ghavamian R; Bergstralh EJ; Blute ML; Slezak J; Zincke H
    J Urol; 1999 Apr; 161(4):1223-7; discussion 1227-8. PubMed ID: 10081874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of microinvasion of the capsule and/or micrometastasis of regional lymph nodes on disease free survival after radical prostatectomy.
    Hering F; Schmid HP; Graber P
    Ann Urol (Paris); 1994; 28(4):196-201. PubMed ID: 7979209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical prostatectomy for clinical T4 prostate cancer.
    Johnstone PA; Ward KC; Goodman M; Assikis V; Petros JA
    Cancer; 2006 Jun; 106(12):2603-9. PubMed ID: 16700037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radical prostatectomy for clinical stage T3a disease.
    Freedland SJ; Partin AW; Humphreys EB; Mangold LA; Walsh PC
    Cancer; 2007 Apr; 109(7):1273-8. PubMed ID: 17315165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histomorphologic studies of prostate biopsies, prostatectomy preparations and lymph node metastases in prostatic cancer].
    Schubert J; Battke H; Hoffmann L; Raatzsch H
    Z Urol Nephrol; 1984 Sep; 77(9):521-8. PubMed ID: 6506894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Present status and questions on early prostatic cancer (stage A, B)].
    Oishi K; Arai Y; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1991 Aug; 37(8):789-93. PubMed ID: 1957722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in prostate cancer incidence and mortality in New Mexico are consistent with an increase in effective screening.
    Gilliland F; Becker TM; Smith A; Key CR; Samet JM
    Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):105-11. PubMed ID: 8049631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.
    Boorjian SA; Thompson RH; Siddiqui S; Bagniewski S; Bergstralh EJ; Karnes RJ; Frank I; Blute ML
    J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.
    Freedland SJ; Presti JC; Terris MK; Kane CJ; Aronson WJ; Dorey F; Amling CL;
    J Urol; 2003 Jun; 169(6):2129-35. PubMed ID: 12771734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of radical prostatectomy in cT3 prostate carcinoma].
    Van Poppel H; Goethuys H; Callewaert P; Vanuytsel L; Van de Voorde W; Baert L
    Praxis (Bern 1994); 2001 Sep; 90(38):1623-31. PubMed ID: 11675915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.